BlackRock Institutional Trust’s WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS WX Stock Holding History

BlackRock Institutional Trust’s Portfolio WX Stock Details WX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-208	Closed	-$7K	–	3944
2014 Q4	$7K	Buy	+208	New	+$7.35K	﹤0.01%	3872
2014 Q2	–	Sell	-8,317	Closed	-$307K	–	4096
2014 Q1	$307K	Sell	8,317 -14,086	-63%	-$517K	﹤0.01%	3651
2013 Q4	$860K	Buy	22,403 +13,979	+166%	+$441K	﹤0.01%	3438
2013 Q3	$231K	Sell	8,424 -17,257	-67%	-$409K	﹤0.01%	3659
2013 Q2	$539K	Buy	+25,681	New	+$501K	﹤0.01%	3468

Other funds holding WX

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

MICM

Matthews International Capital Management San Francisco, California $246M AUM 10.45% 1-Year Est. Return

CBOA

Commonwealth Bank of Australia Sydney, NSW, Australia $231M AUM

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

CGI

Comgest Global Investors Paris, France $4.59B AUM 12.96% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

ACM

Apex Capital Management Dayton, Ohio $4.54B AUM 1.74% 1-Year Est. Return

BlackRock Institutional Trust's WX Position: Q1 2015 in Review

BlackRock Institutional Trust sold out of WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS (WX) in Q1 2015, closing a stake of 208 shares — an estimated $7K sold.

BlackRock Institutional Trust first reported a position in WX in Q2 2013 and held it in 5 quarters. The position peaked at $860K in Q4 2013. 147 funds tracked by Wall St. Rank hold WX as of Q1 2015.

BlackRock Institutional Trust reported no remaining WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS position as of Q1 2015 after selling out during the quarter.
BlackRock Institutional Trust sold 208 WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS shares in Q1 2015, an estimated $7K.
BlackRock Institutional Trust first reported a position in WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS in Q2 2013 and held it in 5 quarters.
BlackRock Institutional Trust's WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS position peaked at $860K in Q4 2013.
147 funds tracked by Wall St. Rank held WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS as of Q1 2015.

Based on BlackRock Institutional Trust's 13F filing for Q1 2015, filed 13 May 2015.